The landscape of clinical trials for heavily pretreated multiple myeloma: opportunity for more randomization?

被引：0

作者：

Kapur, Rohan ^{[1
]}

Mccarron, John ^{[2
]}

Rajeeve, Sridevi ^{[3
]}

Mohyuddin, Ghulam Rehman ^{[4
]}

机构：

[1] Maimonides Hosp, Brooklyn, NY USA

[2] Univ Utah, Salt Lake City, UT USA

[3] Mem Sloan Kettering Canc Ctr, New York, NY USA

[4] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

来源：

LEUKEMIA & LYMPHOMA | 2025年 / 66卷 / 02期

关键词：

THERAPY;

D O I：

10.1080/10428194.2024.2411625

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：355 / 357

页数：3

共 50 条

[1] Outcomes with Panobinostat in Heavily Pretreated Multiple Myeloma Patients
Pan, Darren
Mouhieddine, Tarek H.
Upadhyay, Ranjan
Casasanta, Nicole
Lee, Angela
Zubizarreta, Nicole
Moshier, Erin
Richter, Joshua
BLOOD, 2022, 140 : 12483 - 12484
[2] Domestic opportunity in heavily pretreated multiple myeloma not eligible to hospitalbased treatment: role of pomalidomide-dexamethasone
Cerchione, Claudio
Nappi, Davide
Catalano, Lucio
Musuraca, Gearardo
Ronconi, Sonia
Cangini, Delia
Ceccolini, Michela
Marchesini, Matteo
Pane, Fabrizio
Martinelli, Giovanni
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S136 - S137
[3] Outcomes with panobinostat in heavily pretreated multiple myeloma patients
Pan, Darren
Mouhieddine, Tarek H.
Upadhyay, Ranjan
Casasanta, Nicole
Lee, Angela
Zubizarreta, Nicole
Moshier, Erin
Richter, Joshua
SEMINARS IN ONCOLOGY, 2023, 50 (1-2) : 40 - 48
[4] Domestic Opportunity in Heavily Pretreated Multiple Myeloma Not Eligible for Hospital-Based Treatment: Role of PomalidomideDexamethasone
Cerchione, Claudio
Catalano, Lucio
Nappi, Davide
Ronconi, Sonia
Cangini, Delia
Ceccolini, Michela
Musuraca, Gerardo
Marchesini, Matteo
Martinelli, Giovanni
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S427 - S427
[5] Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
Usmani, Saad Z.
Weiss, Brendan M.
Plesner, Torben
Bahlis, Nizar J.
Belch, Andrew
Lonial, Sagar
Lokhorst, Henk M.
Voorhees, Peter M.
Richardson, Paul G.
Chari, Ajai
Sasser, A. Kate
Axel, Amy
Feng, Huaibao
Uhlar, Clarissa M.
Wang, Jianping
Khan, Imran
Ahmadi, Tahamtan
Nahi, Hareth
BLOOD, 2016, 128 (01) : 37 - 44
[6] Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
Usmani, Saad
Weiss, Brendan
Bahlis, Nizar J.
Belch, Andrew
Lonial, Sagar
Lokhorst, Henk
Voorhees, Peter M.
Richardson, Paul G.
Sasser, A. Kate
Axel, Amy
Feng, Huaibao
Uhlar, Clarissa
Wang, Jianping
Khan, Imran
Ahmadi, Tahamtan
Nahi, Hareth
BLOOD, 2015, 126 (23)
[7] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
Cerchione, Claudio
Martinelli, Giovanni
Catalano, Lucio
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S5 - S5
[8] Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma
Cerchione, Claudio
Catalano, Lucio
Nappi, Davide
Pareto, Anna Emanuele
Basile, Santina
Marano, Luana
Peluso, Ilaria
Simeone, Luigia
Vitagliano, Orsola
Palmieri, Salvatore
Rocco, Stefano
Pane, Fabrizio
Ferrara, Felicetto
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S254 - S255
[9] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
Cerchione, Claudio
Catalano, Lucio
Nappi, Davide
Pareto, Anna Emanuele
Musuraca, Gerardo
Lucchesi, Alessandro
Ronconi, Sonia
Ceccolini, Michela
Cangini, Delia
Giannini, Maria Benedetta
Di Battista, Valeria
Simonetti, Giorgia
Di Rora, Andrea Ghelli Luserna
Pane, Fabrizio
Martinelli, Giovanni
BLOOD, 2020, 136
[10] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
Cerchione, C.
Martinelli, G.
Nappi, D.
Pareto, A. E.
Di Perna, M.
Ferrara, K.
Ronconi, S.
Cangini, D.
Di Battista, V.
Ceccolini, M.
Altini, M.
Pane, F.
Catalano, L.
HAEMATOLOGICA, 2019, 104 : 116 - 116

← 1 2 3 4 5 →